Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-06-20
2008-11-11
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S323000, C514S414000, C514S415000
Reexamination Certificate
active
07449455
ABSTRACT:
The present invention relates to new 2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole compounds having the general structures below:which are useful in contraception and in treating melanoma, osteoporosis, acne, dysfunctional uterine bleeding, endometrial polyps, benign breast disease, adenomyosis, infertility, endometriosis, endometrial cancer, polycystic ovary syndrome, cardiovascular disease, Alzheimer's disease, cognitive decline, central nervous system disorders, central nervous system cancers, leukemia, endometrial ablations, chronic renal disease, chronic hepatic disease, coagulation diseases and disorders, hypocalcemia, hypercalcemia, Paget's disease, osteomalacia, osteohalisteresis, and multiple myeloma.
REFERENCES:
patent: 4943572 (1990-07-01), Von Angerer et al.
patent: 5023254 (1991-06-01), Von Angerer et al.
patent: 5124335 (1992-06-01), Patchett et al.
patent: 5389641 (1995-02-01), Naka et al.
patent: 5496844 (1996-03-01), Inai et al.
patent: 5998402 (1999-12-01), Miller et al.
patent: 6127404 (2000-10-01), Miller et al.
patent: 6225308 (2001-05-01), Miller et al.
patent: 6232307 (2001-05-01), Miller et al.
patent: 6291451 (2001-09-01), Miller et al.
patent: 6362367 (2002-03-01), Braithwaite et al.
patent: 6787538 (2004-09-01), Miller et al.
patent: 6835729 (2004-12-01), Miller et al.
patent: 6924281 (2005-08-01), Miller et al.
patent: 6951852 (2005-10-01), Miller et al.
patent: 7041663 (2006-05-01), Miller et al.
patent: 7132417 (2006-11-01), Miller et al.
patent: 7138392 (2006-11-01), Miller et al.
patent: 7247624 (2007-07-01), Miller et al.
patent: 0 639 567 (1995-02-01), None
patent: WO 93/10741 (1993-06-01), None
patent: WO 93/23374 (1993-11-01), None
patent: WO 95/17383 (1995-06-01), None
patent: WO 96/03375 (1996-02-01), None
patent: WO 00/51983 (2000-09-01), None
Biberger, 2-Phenylindoles with Sulfer Containing Side Chains, CA 125:316191, 1996.
Biberger et al., “2-Phenylindoles with sulfer containing side chains. Estrogen receptor affinity, antiestrogenic potency, and antitumor activity.”, J. Steroid Biochem. Molec. Biol, 58(1):31-43, Apr. 1996.
Hendersen et al., Ann. N.Y. Aca. Sci. pp. 176, 177 and 189, 1995.
Oparil, Hypertension in Postmenopausal Women: Pathology and Management EMBASE 95:283951, 1995.
Von Angerer et al., “1-(aminoalkyl)-2-phenylindoles as novel pure estrogen antagonists”, J. Med. Chem., 33(9):2635-2640, Sep. 1990.
Von Angerer et al., Amer. Chem. Soc., 132-136, 1986.
Von Angerer et al, “2-Phenylindoles. Relationship between structure, estrogen receptor affinity, and mammary tumor inhibiting activity in the rat.”, J. Med. Chem, 27(11):1439-1447, Nov. 1984.
Collini Michael D.
Miller Chris P.
Santilli Arthur A.
Tran Bach D.
Howson & Howson LLP
Kifle Bruck
Milowsky Arnold S.
Wyeth
LandOfFree
2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4023508